OptimizeRx Corp Annual Cost of Revenue in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
OptimizeRx Corp quarterly/annual Cost of Revenue history and growth rate from 2018 to 2024.
  • OptimizeRx Corp Cost of Revenue for the quarter ending December 31, 2024 was $10.3M, a 2.23% decline year-over-year.
  • OptimizeRx Corp Cost of Revenue for the twelve months ending December 31, 2024 was $32.7M, a 14.4% increase year-over-year.
  • OptimizeRx Corp annual Cost of Revenue for 2024 was $32.7M, a 14.4% increase from 2023.
  • OptimizeRx Corp annual Cost of Revenue for 2023 was $28.6M, a 21.9% increase from 2022.
  • OptimizeRx Corp annual Cost of Revenue for 2022 was $23.5M, a 8.46% decline from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $32.7M +$4.13M +14.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $28.6M +$5.14M +21.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 $23.5M -$2.17M -8.46% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 $25.7M +$6.45M +33.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $19.2M +$10M +110% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-03-10
2019 $9.16M +$159K +1.77% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 $9M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.